253 related articles for article (PubMed ID: 28928213)
1. Cell Cycle Inhibition To Treat Sleeping Sickness.
Epting CL; Emmer BT; Du NY; Taylor JM; Makanji MY; Olson CL; Engman DM
mBio; 2017 Sep; 8(5):. PubMed ID: 28928213
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.
Hofer A; Steverding D; Chabes A; Brun R; Thelander L
Proc Natl Acad Sci U S A; 2001 May; 98(11):6412-6. PubMed ID: 11353848
[TBL] [Abstract][Full Text] [Related]
3. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
[TBL] [Abstract][Full Text] [Related]
4. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
[TBL] [Abstract][Full Text] [Related]
5. The in vitro efficacy of reuterin on the culture and bloodstream forms of Trypanosoma brucei brucei.
Yunmbam MK; Roberts JF
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Feb; 101(2):235-8. PubMed ID: 1354096
[TBL] [Abstract][Full Text] [Related]
6. Allosteric regulation of Trypanosoma brucei ribonucleotide reductase studied in vitro and in vivo.
Hofer A; Ekanem JT; Thelander L
J Biol Chem; 1998 Dec; 273(51):34098-104. PubMed ID: 9852067
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164
[TBL] [Abstract][Full Text] [Related]
9. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
[TBL] [Abstract][Full Text] [Related]
10. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48.
Martínez-García M; Bart JM; Campos-Salinas J; Valdivia E; Martínez-Bueno M; González-Rey E; Navarro M; Maqueda M; Cebrián R; Pérez-Victoria JM
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):203-212. PubMed ID: 29649664
[TBL] [Abstract][Full Text] [Related]
11. Designing sleeping sickness control.
Kinoshita T
ACS Chem Biol; 2008 Oct; 3(10):601-3. PubMed ID: 18928247
[TBL] [Abstract][Full Text] [Related]
12. Chemical proteomic analysis reveals the drugability of the kinome of Trypanosoma brucei.
Urbaniak MD; Mathieson T; Bantscheff M; Eberhard D; Grimaldi R; Miranda-Saavedra D; Wyatt P; Ferguson MA; Frearson J; Drewes G
ACS Chem Biol; 2012 Nov; 7(11):1858-65. PubMed ID: 22908928
[TBL] [Abstract][Full Text] [Related]
13. N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.
Frearson JA; Brand S; McElroy SP; Cleghorn LA; Smid O; Stojanovski L; Price HP; Guther ML; Torrie LS; Robinson DA; Hallyburton I; Mpamhanga CP; Brannigan JA; Wilkinson AJ; Hodgkinson M; Hui R; Qiu W; Raimi OG; van Aalten DM; Brenk R; Gilbert IH; Read KD; Fairlamb AH; Ferguson MA; Smith DF; Wyatt PG
Nature; 2010 Apr; 464(7289):728-32. PubMed ID: 20360736
[TBL] [Abstract][Full Text] [Related]
14. Activity of Aromathecins against African Trypanosomes.
Nenortas NP; Cinelli MA; Morrell AE; Cushman M; Shapiro TA
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104277
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
Lüscher A; de Koning HP; Mäser P
Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
[TBL] [Abstract][Full Text] [Related]
16. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
Tang SC; Shapiro TA
Antimicrob Agents Chemother; 2010 Feb; 54(2):620-6. PubMed ID: 20008775
[TBL] [Abstract][Full Text] [Related]
17. Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine.
Steverding D; Rushworth SA
Exp Parasitol; 2017 Jul; 178():45-50. PubMed ID: 28552794
[TBL] [Abstract][Full Text] [Related]
18. Bromodomain Proteins Contribute to Maintenance of Bloodstream Form Stage Identity in the African Trypanosome.
Schulz D; Mugnier MR; Paulsen EM; Kim HS; Chung CW; Tough DF; Rioja I; Prinjha RK; Papavasiliou FN; Debler EW
PLoS Biol; 2015 Dec; 13(12):e1002316. PubMed ID: 26646171
[TBL] [Abstract][Full Text] [Related]
19. A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.
Crona M; Codó P; Jonna VR; Hofer A; Fernandes AP; Tholander F
Mol Oncol; 2016 Nov; 10(9):1375-1386. PubMed ID: 27511871
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides.
Bacchi CJ; Sanabria K; Spiess AJ; Vargas M; Marasco CJ; Jimenez LM; Goldberg B; Sufrin JR
Antimicrob Agents Chemother; 1997 Oct; 41(10):2108-12. PubMed ID: 9333033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
